Related Experiment Videos
[A case of facial apraxia--especially with regard to developmental apraxic dysarthria (author's transl)]
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Consideration for the appropriate use of antimicrobials in long-term care wards.
Infection prevention in practice·2026
An improved automated one-pot synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) based on a purification by cartridges.
Nuclear medicine and biology·2019
Longitudinal changes in 18 F-THK5351 positron emission tomography in corticobasal syndrome.
European journal of neurology·2019
Predicting the therapeutic effect of carbamazepine in trigeminal neuralgia by analysis of neurovascular compression utilizing magnetic resonance cisternography.
International journal of oral and maxillofacial surgery·2018
The OncoSim model: development and use for better decision-making in Canadian cancer control.
Current oncology (Toronto, Ont.)·2017
[The Current Issues of Crime Victim Support from a Clinical Point of View].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019
[The Role of Psychiatrists as Personal Support Specialists].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019
[Historical Re-evaluation of the System of Sending Psychiatrists to Okinawa and the Activities of the Japanese Society of Psychiatry and Neurology].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019
[Background of Okinawa's Acceptance of Dispatched Physicians and Its Current Status].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019
[Medical Dispatch to Okinawa and following Period].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019
[The Situation of Psychiatric Medicine and the System of Dispatching Medical Doctors Half a Century Ago in Okinawa].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019
Donanemab for early symptomatic AD in the UK-indicated population: safety and efficacy in those who are non-carriers or heterozygous for APOE ε4.
Neurodegenerative disease management·2026